Shaolin Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$4.33K Sell
2024
Q2
$18.9K Hold
2024
Q1
$23.4K Hold
2023
Q4
$22.5K Sell
2023
Q3
$143K Buy
2023
Q2
Sell
2023
Q1
$25K Buy
2022
Q4
$25K Hold
2022
Q3
$28K Hold
2022
Q2
$45K Sell
2022
Q1
$179K Buy